Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1983 November; 76(11): 943–946.
PMCID: PMC1439653

What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (568K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bleyer WA, Haas JE, Feigl P, Greenlee TK, Schaller RT, Jr, Morgan A, Pendergrass TW, Johnson FL, Bernstein ID, Chard RL, Jr, et al. Improved three-year disease-free survival in osteogenic sarcoma. J Bone Joint Surg Br. 1982;64(2):233–238. [PubMed]
  • Cores EP, Holland JF, Wang JJ, Sinks LF. Doxorubicin in disseminated osteosarcoma. JAMA. 1972 Sep 4;221(10):1132–1138. [PubMed]
  • Djerassi I. Methotrexate infusions and intensive supportive care in the management of children with acute lymphocytic leukemia: follow-up report. Cancer Res. 1967 Dec;27(12):2561–2564. [PubMed]
  • Edmonson JH, Green SJ, Ivins JC, Gilchrist GS, Cregan ET, Pritchard DJ, Smithson WA, Dahlin DC, Taylor WF. Methotrexate as adjuvant treatment for primary osteosarcoma. N Engl J Med. 1980 Sep 11;303(11):642–643. [PubMed]
  • Ettinger LJ, Douglass HO, Jr, Higby DJ, Mindell ER, Nime F, Ghoorah J, Freeman AI. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer. 1981 Jan 15;47(2):248–254. [PubMed]
  • Evans AE, Heyn RM, Nesbit ME, Hartmann JR. Evaluation of mitomycin C (NSC-26980) in the treatment of metastatic osteogenic sarcoma. Cancer Chemother Rep. 1969 Oct;53(5):297–298. [PubMed]
  • Finklestein JZ, Hittle RE, Hammond GD. Evaluation of a high dose cyclophosphamide regimen in childhood tumors. Cancer. 1969 May;23(5):1239–1242. [PubMed]
  • Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer. 1972 Dec;30(6):1627–1631. [PubMed]
  • Jaffe N, Frei E, 3rd, Traggis D, Bishop Y. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med. 1974 Nov 7;291(19):994–997. [PubMed]
  • Jaffe N, Frei E, 3rd, Traggis D, Watts H. Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases. Cancer. 1977 Jan;39(1):45–50. [PubMed]
  • Jaffe N, Frei E, 3rd, Watts H, Traggis D. High-dose methotrexate in osteogenic sarcoma: a 5-year experience. Cancer Treat Rep. 1978 Feb;62(2):259–264. [PubMed]
  • Jaffe N, Traggis D, Enriquez C. Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma. Cancer Chemother Rep. 1971 Apr;55(2):189–191. [PubMed]
  • Lange B, Levine AS. Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma? Cancer Treat Rep. 1982 Sep;66(9):1699–1704. [PubMed]
  • Mosende C, Gutierrez M, Caparros B, Rosen G. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer. 1977 Dec;40(6):2779–2786. [PubMed]
  • Ochs JJ, Freeman AI, Douglass HO, Jr, Higby DS, Mindell ER, Sinks LF. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep. 1978 Feb;62(2):239–245. [PubMed]
  • Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982 Mar 15;49(6):1221–1230. [PubMed]
  • Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979 Jun;43(6):2163–2177. [PubMed]
  • Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976 Jan;37(1):1–11. [PubMed]
  • Rosen G, Nirenberg A. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe. Cancer Treat Rep. 1982 Sep;66(9):1687–1697. [PubMed]
  • Rosen G, Suwansirikul S, Kwon C, Tan C, Wu SJ, Beattie EJ, Jr, Murphy ML. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer. 1974 Apr;33(4):1151–1163. [PubMed]
  • Rosenburg SA, Chabner BA, Young RC, Seipp CA, Levine AS, Costa J, Hanson TA, Head GC, Simon RM. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation. Cancer Treat Rep. 1979 May;63(5):739–751. [PubMed]
  • Sutow WW, Gehan EA, Dyment PG, Vietti T, Miale T. Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. Cancer Treat Rep. 1978 Feb;62(2):265–269. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press